U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099053) titled 'Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging' on July 31.
Brief Summary: Background:
Some people experience cognitive decline as they age. That is, they lose memory, problem-solving, and other mental abilities. Amyloids are groups of proteins that develop in the brain and increase in number as people age. Researchers want to use imaging scans to track amyloids in people s brains over time. Their goal is to find out if any changes are related to cognitive decline or other medical issues.
Objective:
To learn how amyloids may affect brain structure and function as people age.
Eligibility:
People aged 55 years an...